Soaring Demand Set to Propel Transcriptomics Market to $9.57 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Transcriptomics Market Through 2025?
The overall valuation of the transcriptomics sector has experienced robust expansion lately; projected figures indicate an ascent from a valuation of $6.51 billion in the year 2024 to $7.04 billion come 2025, reflecting a compound annual growth rate (CAGR) of 8.2%. This upward trajectory during the past period stems from several key drivers, including the intensified concentration on individualized medical treatments, the rising incidence rates of various cancers, the broader incorporation of genomic technologies into clinical testing methodologies, the continuous scaling of ribonucleic acid sequencing capabilities, and elevated requirements for identifying biological indicators.

What's the Projected Size of the Global Transcriptomics Market by 2029?
Anticipation surrounds the transcriptomics sector, projecting significant expansion in the ensuing years, with its valuation slated to reach $9.57 billion by 2029, supported by a robust compound annual growth rate (CAGR) of 8.0%. This forward trajectory stems from several key factors, notably the escalating uptake of single-cell RNA sequencing methods, the deepening incorporation of spatial transcriptomics, the surging requirement for multiomics strategies, greater emphasis on identifying ailments prematurely, and heightened recognition concerning the significance of non-coding RNAs. During this projection timeframe, several key developments are anticipated, such as innovations in next-generation sequencing (NGS) platforms, progress in spatial transcriptomics instrumentation, maturation of bioinformatics software, the weaving of machine learning into transcriptomic research, and enhancements in techniques for analyzing transcriptomes instantaneously.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

Top Growth Drivers in the Transcriptomics Industry: What's Accelerating the Market?
The burgeoning embrace of tailored healthcare solutions is anticipated to be a significant catalyst for the expansion of the transcriptomics sector in the near future. This customized approach to healthcare involves tailoring medical interventions to an individual's specific genetic makeup, daily habits, and surroundings. Progress in genetic sequencing technologies, which facilitate the design of treatments precisely aligned with individual genetic blueprints for superior outcomes, is fueling the momentum of personalized medicine. Transcriptomics plays a crucial role by revealing distinct patterns of gene activity, thereby informing customized therapeutic strategies rooted in a patient's singular biological characteristics. This capability elevates the efficacy of treatments, reduces adverse reactions, and facilitates the detection of illnesses at earlier stages. To illustrate, data from the Personalized Medicine Coalition, a US organization focused on healthcare, indicated that in 2023, the FDA authorized sixteen novel personalized therapies for individuals suffering from uncommon ailments during 2023, representing a notable increase from the six approvals granted the prior year in 2022. Consequently, the expanding utilization of individually optimized medical care is directly fueling the upward trajectory of the transcriptomics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp

What Trends Will Shape the Transcriptomics Market Through 2029 and Beyond?
Leading firms participating in the transcriptomics market are concentrating their efforts on innovating sophisticated offerings, notably single-cell spatial panels, with the goal of yielding more profound understandings of how cells function and the underlying processes of illnesses. These panels allow for the examination of gene expression down to the level of individual cells while simultaneously preserving the original anatomical positioning of every cell within the tissue sample itself, thereby integrating singular cell transcriptomic data with spatial context to illuminate both cellular behavior and the organizational structure of the tissue. A concrete example of this progression is the introduction in February 2024 of the CosMx 6,000 plex RNA Assay by NanoString Technologies, a biotechnology entity situated in the United States; this particular spatial molecular imaging assay represented the debut of the first commercially accessible single-cell spatial panel capable of quantifying upwards of 6,000 RNA targets that span essentially every recognized human biological pathway, a development intended for utilization with NanoString's CosMx Spatial Molecular Imager (SMI) that empowers researchers to attain high-fidelity gene profiling at both single-cell and subcellular resolution, complete with sophisticated methods for cell delineation.

What Are the Main Segments in the Transcriptomics Market?
The transcriptomicsmarket covered in this report is segmented -

1) By Type: Instruments; Consumables; Software; Services
2) By Technology: Micro Array; Real-Time Quantitative Polymerase Chain Reaction; Sequencing Technologies
3) By Application: Diagnostics And Disease Profiling; Drug Discovery; Other Applications
4) By End-User: Academic And Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Other End-Users

Subsegments:
1) By Instruments: Microarray Instruments; Sequencing Instruments; Polymerase Chain Reaction (PCR) Instruments; Other Transcriptomics Instruments
2) By Consumables: Reagents; Probes; Kits; Chips
3) By Software: Data Analysis Software: Data Management Software; Visualization Software: Bioinformatics Software
4) By Services: Data Analysis Services; Sample Preparation Services; Sequencing Services; Consulting Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24417&type=smp

Which Top Companies are Driving Growth in the Transcriptomics Market?
Major companies operating in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton dic*kinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, Arraystar Inc.

Which Regions Will Dominate the Transcriptomics Market Through 2029?
North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24417

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.